Skip to main content
Log in

Cancer Immunology, Immunotherapy

Publishing model:
Open access

Overview

Cancer Immunology, Immunotherapy is providing a timely and open access publication of original discovery and developments in basic and translational research in the field of cancer immunology and immunotherapy.

Editor-in-Chief
  • Haidong Dong
Impact factor
4.6 (2023)
5 year impact factor
5.4 (2023)
Submission to first decision (median)
4 days
Downloads
1,142,964 (2023)

Latest articles

Journal updates

Journal information

Electronic ISSN
1432-0851
Print ISSN
0340-7004
Abstracted and indexed in
  1. AGRICOLA
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. Biological Abstracts
  6. CLOCKSS
  7. CNKI
  8. CNPIEC
  9. Chemical Abstracts Service (CAS)
  10. Current Contents/Life Sciences
  11. Dimensions
  12. EBSCO
  13. EMBASE
  14. Google Scholar
  15. Japanese Science and Technology Agency (JST)
  16. Medline
  17. Naver
  18. Norwegian Register for Scientific Journals and Series
  19. OCLC WorldCat Discovery Service
  20. Pathway Studio
  21. Portico
  22. ProQuest
  23. PubMedCentral
  24. Reaxys
  25. SCImago
  26. SCOPUS
  27. Science Citation Index Expanded (SCIE)
  28. Semantic Scholar
  29. TD Net Discovery Service
  30. UGC-CARE List (India)
  31. Wanfang
Copyright information

Rights and permissions

Editorial policies

© Springer-Verlag GmbH Germany, part of Springer Nature

Navigation